State Street’s Apollo Endosurgery, Inc. APEN Stock Holding History

State Street’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-140,566	Closed	-$1.39M	–	4827
2023 Q1	$1.39M	Buy	140,566 +22,600	+19%	+$224K	﹤0.01%	3439
2022 Q4	$1.18M	Buy	117,966 +28,600	+32%	+$213K	﹤0.01%	3524
2022 Q3	$492K	Hold	89,366	–	–	﹤0.01%	3785
2022 Q2	$326K	Hold	89,366	–	–	﹤0.01%	3996
2022 Q1	$541K	Buy	89,366 +30,466	+52%	+$186K	﹤0.01%	4022
2021 Q4	$497K	Buy	58,900 +19,900	+51%	+$174K	﹤0.01%	4031
2021 Q3	$353K	Buy	39,000 +7,100	+22%	+$61K	﹤0.01%	4113
2021 Q2	$258K	Buy	+31,900	New	+$219K	﹤0.01%	4120

State Street's APEN Position: Q2 2023 in Review

State Street sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 140,566 shares — an estimated $1.39M sold.

State Street first reported a position in APEN in Q2 2021 and held it in 8 quarters. The position peaked at $1.39M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

State Street reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
State Street sold 140,566 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.39M.
State Street first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 8 quarters.
State Street's Apollo Endosurgery, Inc. position peaked at $1.39M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.